Alemtuzumab (Campath) ( DrugBank: Alemtuzumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
15	封入体筋炎	1

15. 封入体筋炎

臨床試験数 : 42 / 薬物数 : 33 - (DrugBank : 11) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 123

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00079768 (ClinicalTrials.gov)	March 2004	12/3/2004	Alemtuzumab to Treat Sporadic Inclusion Body Myositis	Effects of a T Cell-Depleting Monoclonal Antibody, Alemtuzumab, in Patients With Inclusion Body Myos ...	Myositis, Inclusion Body	Drug: Alemtuzumab (Campath)	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	25 Years	80 Years	Both	20	Phase 2	United States

First Previous1Next Last